الابحاث

South Egypt Cancer Institute

Assiut University

Department of Clinical Pathology
# Title Research Member Research Year
21 Overexpression of PD-1 and CD39 in tumor-infiltrating lymphocytes compared with peripheral blood lymphocytes in triple-negative breast cancer Dr. Dalia Osama Mohamed Ahmed 2022
22 Sinopharm’s BBIBP-CorV Vaccine and ChAdOx1 nCoV-19 Vaccine Are Associated with a Comparable Immune Response against SARS-CoV-2 Dr. Iman Hassan Ahmed Hamada 2022
23 Evaluation of new markers of minimal residual disease in B acute lymphoblastic leukemia Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2022
24 Association of follicular helper T and follicular regulatory T cells with severity and hyperglycemia in hospitalized COVID-19 patients Dr. Asmaa Mohamed Zahran Omar 2022
25 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Dr. Mohamed Galal Mostafa ELnaggar 2021
26 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
 		Dr. Asmaa Mohamed Zahran Omar 2021
27 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2021
28 Relationship of transitional regulatory B and regulatory T cells and immunosuppressive drug doses in stable renal transplant recipients Prof. Douaa Mohamed Sayed Hussein 2021
29 Clinical Outcome of Pediatric Acute Myeloid Leukemia Treated at South Egypt Cancer Institute, Assiut University, Egypt Dr. Iman Hassan Ahmed Hamada 2021
30 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2021